Por favor, use este identificador para citar o enlazar este ítem: https://repositorio.uca.edu.ar/handle/123456789/14248
Título : Thymopentin improves the survival of septic mice by promoting the production of 15-deoxy-prostaglandin J2 and activating the PPARγ signaling pathway
Autor : Zhang, Ye 
Yang, Xue 
Yan, Wenchao 
Li, Rui 
Ye, Qian 
You, Linjun 
Xie, Wenhao 
Mo, Kun 
Fu, Ruifeng 
Wang, Yanxiang 
Chen, Yufei 
Hou, Hui 
Yang, Yong 
Birnbaumer, Lutz 
Di, Qin 
Li, Xianjing 
Palabras clave : CITOQUINASINFLAMACIONSEPSISTIMOPENTINA
Fecha de publicación : 2020
Editorial : Wiley
Federation of American Society of Experimental Biology (FASEB)
Cita : Zhang, Y., et al. Thymopentin improves the survival of septic mice by promoting the production of 15-deoxy-prostaglandin J2 and activating the PPARγ signaling pathway [en línea]. FASEB Journal. 2020, 34(9) doi:10.1096/fj.202000467R Disponible en: https://repositorio.uca.edu.ar/handle/123456789/14248
Resumen : Abstract: Sepsis, a systemic inflammatory response syndrome (SIRS) caused by infection, is a major public health concern with limited therapeutic options. Infection disturbs the homeostasis of host, resulting in excessive inflammation and immune suppression. This has prompted the clinical use of immunomodulators to balance host response as an alternative therapeutic strategy. Here, we report that Thymopentin (TP5), a synthetic immunomodulator pentapeptide (Arg-Lys-Asp-Val-Tyr) with an excellent safety profile in the clinic, protects mice against cecal ligation and puncture (CLP)-induced sepsis, as shown by improved survival rate, decreased level of pro-inflammatory cytokines and reduced ratios of macrophages and neutrophils in spleen and peritoneum. Regarding mechanism, TP5 changed the characteristics of LPS-stimulated macrophages by increasing the production of 15-deoxy-Δ12,14 -prostaglandin J2 (15-d-PGJ2). In addition, the improved effect of TP5 on survival rates was abolished by the peroxisome proliferator-activated receptor γ (PPARγ) antagonist GW9662. Our results uncover the mechanism of the TP5 protective effects on CLP-induced sepsis and shed light on the development of TP5 as a therapeutic strategy for lethal systemic inflammatory disorders.
URI : https://repositorio.uca.edu.ar/handle/123456789/14248
ISSN : 0892-6638
1530-6860 (online)
Disciplina: MEDICINA
DOI: 10.1096/fj.202000467R
Derechos: Acceso abierto
Aparece en las colecciones: Artículos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato
thymopentin-improves-survival.pdf1,55 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro Dublin Core completo del ítem

Visualizaciones de página(s)

100
comprobado en 28-mar-2024

Descarga(s)

92
comprobado en 28-mar-2024

Google ScholarTM

Consultar


Altmetric


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons